Evofem Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $110.0M
Liabilities Breakdown FY2020
Total Liabilities: $108.6M
Asset Breakdown
Total Assets: $110.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $48.9M | 44.5% |
| Accounts Receivable | $1.1M | 1.0% |
| Inventory | $7.2M | 6.5% |
| Property, Plant & Equipment | $4.3M | 3.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $48.5M | 44.1% |
Liabilities Breakdown
Total Liabilities: $108.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.6M | 9.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $98.0M | 90.2% |